hmpl-013 has been researched along with Stomach-Neoplasms* in 1 studies
1 other study(ies) available for hmpl-013 and Stomach-Neoplasms
| Article | Year |
|---|---|
A phase Ib/II study of fruquintinib in combination with paclitaxel as the second-line therapy for advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzofurans; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Paclitaxel; Quinazolines; Stomach Neoplasms | 2023 |